Graph Therapeutics
Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis
$5MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis